![Michael Didocha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Didocha
Corporate Officer/Principal chez
TELIX PHARMACEUTICALS LIMITED
Profil
Michael Didocha is currently the Chief Financial Officer-American Region at Telix Pharmaceuticals Ltd. He previously worked as a Finance Director at Roche Holding AG.
Mr. Didocha completed his undergraduate degree at Georgia Institute of Technology and holds an MBA from Kelley School of Business.
Postes actifs de Michael Didocha
| Sociétés | Poste | Début |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Corporate Officer/Principal | 31/08/2021 |
Anciens postes connus de Michael Didocha
| Sociétés | Poste | Fin |
|---|---|---|
| ROCHE HOLDING AG | Directeur Financier/CFO | - |
Formation de Michael Didocha
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
37
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Georgia Institute of Technology
 Georgia Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Telix Pharmaceuticals Ltd.
 Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
